Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-centre, Open-label, First-in-man Study With Epipad Used in Adult Patients

NCT05618496 is registered in ClinicalTrials.gov with Contipro Pharma a.s. as lead sponsor.

NCT NCT05618496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05618496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-centre, Open-label, First-in-man Study With Epipad Used in Adult Patients
Lead sponsor
Contipro Pharma a.s.
Phase
Not applicable
Overall status
Completed
Start date
October 26, 2022
Completion date
October 31, 2023
Enrollment
52 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

wound